Table 2.
Correlation between AS-tDR-007872 expression and clinicopathological parameters of lung cancer.
| NSCLC (%) | Healthy volunteers (%) | p valuea | |
|---|---|---|---|
| Gender | 0.084 | ||
| Male | 54 (68.4) | 18 (51.4) | |
| Female | 25 (31.6) | 17 (48.6) | |
| Age (years) | |||
| ≥65 | 38 (48.1) | 3 (8.6) | |
| <65 | 41 (51.9) | 32 (91.4) | |
| Histological subtype | |||
| PADC | 52 (65.8) | ||
| LSCC | 27 (34.2) | ||
| Pathological tumor size | |||
| T1/T2 | 25 (31.6) | ||
| T3/T4 | 54 (68.4) | ||
| Pathological lymph node metastasis | |||
| Positive | 60 (75.9) | ||
| Negative | 19 (24.1) | ||
| Pathological stage | |||
| I-IIIA | 22 (27.8) | ||
| IIIB-IV | 57 (72.2) | ||
| Smoking habit | |||
| Yes | 37 (46.8) | ||
| No | 42 (53.2) | ||
| Pack-years | |||
| 0 | 37 (46.8) | ||
| 1-20 | 12 (15.2) | ||
| 21-49 | 16 (20.3) | ||
| >49 | 14 (17.7) | ||
aChi-squared test. NSCLC: non-small-cell lung carcinoma; PADC: pulmonary adenocarcinoma; LSCC: lung squamous cell carcinoma.